Call for Abstract

4thAnnual Conference on Preventive Oncology, will be organized around the theme “An Ounce of Prevention is Worth a Pound of Cure”

Preventive Oncology 2018 is comprised of 24 tracks and 232 sessions designed to offer comprehensive sessions that address current issues in Preventive Oncology 2018.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

Preventive oncology is any measure that is taken to prevent development or progression of malignant process. Around one third of cancer deaths are due to the five leading behavioral and dietary risks: high body mass index, low fruit and vegetable intake, lack of physical activity, tobacco use, alcohol use, and one half of all cancer cases either arise from modifiable risk factors or can be detected as precursor lesions before the development of disease with metastatic potential.

 Prevention of cancer can take place on several different levels: primary prevention addresses the cause of cancer so disease does not occur, secondary prevention identifies disease before the onset of symptoms and keeps it from becoming more extensive, and tertiary prevention reduces complications and progression of disease once it has become clinically apparent. 

  • Track 1-1Uterine Cancer
  • Track 1-2Vulvar Cancer
  • Track 1-3Screening Guidelines for Cancer detection
  • Track 1-4Palliative Care
  • Track 1-5Clinical and Laboratory aspects of Cancer detection
  • Track 1-6Novel Therapeutic Approaches
  • Track 1-7Methodological issues of cancer detection
  • Track 1-8Public awareness and Professional education
  • Track 1-9Rare Gynecological Tumors

The cell is the key unit of life. It is the littlest structure of the body equipped for playing out the majority of the procedures that characterize life. Each of the organs in the body, for example, the lung, bosom, colon, and cerebrum, comprises of specific cells that complete the organ's capacities, for example, the transportation of oxygen, assimilation of supplements, discharge of waste materials, velocity, generation, considering. when this process breaks down, cancer begins to form. Cancer cells will be cells that gap persistently, shaping strong tumors or flooding the blood with unusual cells. Cell division is a typical procedure utilized by the body for development and repair.

  • Track 2-1Cell cycle
  • Track 2-2Cancer risk factor
  • Track 2-3Cancer biology
  • Track 2-4Cellular Pathology
  • Track 2-5Cancer Metabolism

The branch of Oncology dealing with Radiation therapy is termed as Radiation Oncology. The Radiotherapy is broadly segmented into Teleradiotherapy, Brachy-radiotherapy and Metabolic Radiotherapy. Tele-radiotherapy, also called as External transcutaneous / distant radiotherapy, is a method in which the radiation source is situated at a certain distance from the tissue to be treated. Brachytherapy, also termed as Short direct radiotherapy /Curitherapy, is a method in which radiation source can be placed in contact with the tumor or it can be implanted in the tumor. Curative radiotherapy is indicated to be used in: Sticker’s sarcoma, Mastocytomas with particular locations, such as ears, nose, extremities, eyelids; Nasal cavity adenocarcinoma and Anal gland adenocarcinoma. Stereotactic radiosurgery is a single-day procedure for treating small intracranial lesions. Metabolic radiotherapy represents the administration of isotopes or isotope carrying molecules that selectively concentrate in a certain tissue into which they enter as metabolites. For Example; iodine-131is used in treating Thyroid cancer; phosphorus-32 is used in treating Myeloproliferative disorders.

  • Track 3-1Radiation Therapy
  • Track 3-2Predictive Oncology
  • Track 3-3Cancer Imaging
  • Track 3-4Stem Cell Therapy
  • Track 3-5Oncology Nursing
  • Track 3-6Radiation therapy
  • Track 3-7Stereotactic body radiation therapy (SBRT)

The branch of medication that arrangements with the conclusion and treatment of harm, disfigurement, and infection by the utilization of instruments. Immature microorganism treatment is the utilization of undifferentiated cells to treat or keep an illness or condition. Undifferentiated organisms have colossal guarantee to help us comprehend and treat a scope of illnesses, wounds and other wellbeing related conditions. Their potential is apparent in the utilization of blood undifferentiated organisms to treat ailments of the blood, a treatment that has spared the lives of a great many youngsters with leukemia; and can be found in the utilization of undeveloped cells for tissue unions to treat infections or harm deep down, skin and surface of the eye. Some bone, skin and corneal (eye) wounds and infections can be dealt with by uniting or embedding tissues, and the mending procedure depends on undifferentiated organisms inside this embedded tissue. A bone marrow transplant is a system to supplant harmed or wrecked bone marrow with solid bone marrow undeveloped cells. 

  • Track 4-1Hormonal Therapy
  • Track 4-2Gene Therapy
  • Track 4-3Neurodegeneration
  • Track 4-4Malignant and non-malignant diseases
  • Track 4-5Stem cell replacement
  • Track 4-6Allogeneic bone marrow transplantation
  • Track 4-7Oral stem cell therapy
  • Track 4-8Stem cells: therapeutic uses
  • Track 4-9Bone marrow Transplantation
  • Track 4-10Proton therapy
  • Track 4-11Stem cell transplantation
  • Track 4-12Immunotherapy
  • Track 4-13LASER and LASIC
  • Track 4-14Targeted Therapy
  • Track 4-15Angiogenesis Inhibitors

Anticancer medications are utilized to treat malignancies, or dangerous developments. Drug treatment might be utilized alone, or in mix with different medicines, for example, surgery or radiation treatment Anti-malignancy medications are utilized to control the development of carcinogenic cells. Malignancy is normally characterized as the uncontrolled development of cells, with loss of separation and ordinarily, with metastasis, spread of the growth to different tissues and organs. Tumors are threatening developments. Interestingly, benevolent developments remain embodied and develop inside a very much characterized region. Albeit kind tumors might be lethal if untreated, because of weight on key organs, as on account of an amiable mind tumor, surgery or radiation are the favored techniques for treating developments which have a very much characterized area. Anticancer medications are utilized when the tumor has spread, or may spread, to all regions of the body.

  • Track 5-1Targeted Anticancer Therapies
  • Track 5-2Anti-Cancer Agents in Medicinal Chemistry
  • Track 5-3Anti-cancer drugs and delivery
  • Track 5-4Cancer Therapy and Clinical Cancer Research
  • Track 5-5Chemotherapy
  • Track 5-6Radiation Therapy
  • Track 5-7Gene Therapy
  • Track 5-8Modern medicine
  • Track 5-9Preventive Oncology Pharmacology
  • Track 5-10Preventive Oncology Stem Cell Therapy
  • Track 5-11Preventive Oncology Drugs
  • Track 5-12Preventive Oncology Vaccines
  • Track 5-13Drugs and mechanism
  • Track 5-14Therapeutic antibodies & cancer vaccines
  • Track 5-15Novel drug delivery system & cancer drug designing
  • Track 5-16Anticancer drugs in global market: economy & their cost effectiveness
  • Track 5-17Nanotechnology in cancer drugs
  • Track 5-18Functional genomics in drug discovery & development


hematologic-oncology is the study that involves in the diagnosis, treatment and/or prevention of blood diseases and cancers such as iron-deficiency anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. This physician is trained in hematology — the study of blood — and oncology — the study of cancer. Hematologist-oncologists do not usually treat operable cancers such as prostate cancer, but specialize in treating blood cancers, such as Hodgkins and non-Hodgkins lymphomas, leukemias and multiple myelomas. A hematologist-oncologist may also specialize in the management of solid tumors.

Hematologist-oncologists often work closely with colleagues from other departments including: radiation-oncology, surgery, radiology and pathology. Other associated specialties include infectious disease, pain medicine and psychology.

Hematologists also conduct studies in oncology and work with oncologists, people who may specialize only in that field instead of both-the medical treatment of cancer. There are various disorders that people are affected by hematology. A few of these different types of blood conditions that are looked at include anemia, hemophilia, general blood clots, bleeding disorders, etc. As for related blood cancers such as leukemia, myeloma, and lymphoma, these are more serious cases that need to be diagnosed

  • Myeloma
  • Myelodysplastic syndromes
  • Multiple Myeloma
  • Leukaemia
  • Lymphoma
  • Track 6-1Acute and Chronic Lymphoblastic Leukemia
  • Track 6-2Hodgkin’s and Non-Hodgkin’s Lymphoma
  • Track 6-3Myelodysplastic Syndromes
  • Track 6-4Myeloma Cancer
  • Track 6-5Myeloid Leukemia
  • Track 6-6Multiple Myeloma

Cancer Diagnostic testing involves tests and procedures to confirm the presence of disease and identify the correct tumor type, location, extent and stage. At Cancer Treatment Centres. We use sophisticated diagnostic technology to pinpoint and evaluate tumors, and develop a personalized treatment plan. Some cancers are diagnosed during routine screening examinations. These are usually tests that are routinely done at a certain age. Many cancers are discovered when you present to your health care professional with specific symptoms.sonalized medicine.

  • Track 7-1A review of health history
  • Track 7-2Physical examination
  • Track 7-3Laboratory tests (blood, urine, etc.)
  • Track 7-4Biopsy
  • Track 7-5Imaging tests (X-ray, PET/CT, MRI, ultrasound, etc.)
  • Track 7-6Nuclear medicine scans (bone scans, etc.)
  • Track 7-7Endoscopy
  • Track 7-8Genetic tests

Molecular and Cellular Oncology's main goal is to improve essential exploration incredibleness by setting up a solid examination bunch concentrated on the sub-atomic and cell parts of growth exploration, especially in sub-atomic and cell flagging pathways for tumor movement and metastasis; to upgrade translational exploration for advancement of focused malignancy treatments; to improve instructive projects for cutting edge researchers.

  • Track 8-1Cell and Molecular Pharmacology & Experimental Therapeutics
  • Track 8-2Genetic
  • Track 8-3Epigenetic
  • Track 8-4Biochemical
  • Track 8-5Oncogene signalling
  • Track 8-6Metabolism
  • Track 8-7Angiogenesis

The most recent energizing examination leap forward for disease treatment is in the field of immuno-oncology. This type of treatment uses or upgrades the patient's own particular insusceptible framework to have the capacity to stop the development of malignancy cells.

The insusceptible framework is the body's common barrier framework. It is an accumulation of organs, cells and exceptional atoms that shields you from contaminations, tumor and different maladies. At the point when an alternate (remote) life form goes into the body, for instance a microscopic organisms, the resistant framework remembers it and after that assaults it, keeping it from creating hurt. This procedure is called an insusceptible reaction. Since malignancy cells are altogether different from typical cells in the body, the resistant framework assaults them when it can remember them. Notwithstanding, disease cells regularly discover approaches to mask themselves as typical cells, so that the safe framework does not generally remember them as unsafe. What's more, like infections, they can change after some time (transform) and hence escape from the insusceptible reaction. Additionally, the characteristic safe reaction to disease cells is frequently not sufficiently solid to battle off growth cells. Immuno-oncology treatments enact our insusceptible framework, making it ready to perceive growth cells and decimate them.

  • Track 9-1Tumor microenvironment
  • Track 9-2Cell and gene therapy
  • Track 9-3Preclinical and clinical development
  • Track 9-4Prediction and Prognosis in Immunotherapy
  • Track 9-5Enhancing Adaptive Anti-Tumor Responses
  • Track 9-6Tumour microenvironment
  • Track 9-7Tumour-associated antigens
  • Track 9-8Antitumor
  • Track 9-9Immune suppression
  • Track 9-10Tumor immunology
  • Track 9-11Immunology

A prognosis is the doctor's best estimate of how cancer will affect a person. Many factors can affect a person's prognosis. Survival statistics are one tool that doctors use to develop a prognosis for a person with cancer. Doctors often look at studies that measure survival for a particular type of cancer, stage or risk group, when developing a prognosis.

There are different types of cancer survival statistics and different ways to measure and report survival. In general, survival is the proportion of people with cancer who are alive at some point in time (such as 1, 3, 5 or 10 years) after their diagnosis. 

  • Track 10-1Stage
  • Track 10-2Characteristics of the cancer
  • Track 10-3Treatments chosen
  • Track 10-4Response to treatment

Gynecologic oncology is a specialized field of medicine that focuses on cancers of the female reproductive system, including ovarian cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer. Cancer of the female reproductive tract also includes the endometrium, fallopian tubes, and vagina. The specialists in this do have extensive training in the diagnosis and treatment of these cancers. By the Aggressive exploitation of operative laparoscopy, even only for selected patients, into the surgical practice of a gynecologic oncology service demonstrates significant improvements in LOS (laparoscopy on length of stay) without adversely affecting surgical complication rates based on different types of cancers. Cervical cancer Endometrial/uterine cancer Gestational trophoblastic disease Ovarian cancer- including fallopian tube, peritoneal, germ cell, and stromal cell Vaginal cancer Vulvar cancer.

  • Track 11-1Cervical cancer
  • Track 11-2Endometrial /Uterine Cancer
  • Track 11-3Gestational trophoblastic disease
  • Track 11-4Vaginal cancer
  • Track 11-5The adnexal mass
  • Track 11-6Epithelial ovarian cancer
  • Track 11-7Breast cancer
  • Track 11-8Sarcoma of the uterus
  • Track 11-9Ovarian Cancer

Pediatic Oncology is a branch of medicine which deals with the medical care of infants, children, and adolescents. The word pediatrics and its cognates mean "healer of children"; they derive from two Greek words: pais "child" and iatros "doctor, healer". The age limit, from birth up to 18-21 yrs. Pediatricians work both in primary care physicians and hospitals, especially they works in a specialized subfields such as neonatology. Paediatric oncologists diagnose, treat, and manage children, suffering from cancers which include leukaemia, lymphomas, brain tumours, bone tumours, and solid tumors. A medical practitioner who specializes in this area is called as a paediatrician. The body of an infant or neonate is substantially physiologically different when compare to an adult. Congenital defects, genetic variance and developmental issues are some greater concern to paediatricians as compare to adult physicians.

  • Track 12-1Pediatric Hematology Oncology
  • Track 12-2Pediatric Radiology
  • Track 12-3Pediatric Neuro- Oncology
  • Track 12-4Pediatric Oncology Diagnosis
  • Track 12-5Pediatric Oncology Treatment
  • Track 12-6Pediatric Oncology Nursing
  • Track 12-7Pediatric Cancer Care
  • Track 12-8Clinical Pediatrics
  • Track 12-9Neuroblastoma
  • Track 12-10Wilms tumor
  • Track 12-11Non-Hodgkin lymphoma
  • Track 12-12 Retinoblastoma
  • Track 12-13Germ Cell Tumor
  • Track 12-14Pleuropulmonary Blastoma
  • Track 12-15Types of Pediatric Oncology
  • Track 12-16Hepatoblastoma

Bone marrow transplantation is the strategy to supplant harmed bone marrow cells with solid bone marrow cells of the same individual or in another good individual to reestablish the ordinary generation of platelets. It is otherwise called Hematopoietic undifferentiated organism transplantation (HSCT). It is the transplantation of multipotent hematopoietic undifferentiated cells, typically got from bone marrow, fringe blood, or umbilical line blood. It might be autologous (the patient's own particular foundational microorganisms are utilized), allogeneic (the immature microorganisms originate from a giver) or syngeneic ( from an indistinguishable twin ). It is a restorative strategy in the field of hematology, frequently performed for patients with specific malignancies of the blood or bone marrow, for example, numerous myeloma or leukemia. In these cases, the beneficiary's safe framework is typically demolished with radiation or chemotherapy before the transplantation. Contamination and joining versus-host malady are real entanglements of allogeneic HSCT.

  • Track 13-1Autologous Bone marrow Transplantation
  • Track 13-2Allogeneic Bone marrow Transplantation
  • Track 13-3Syngeneic Bone marrow Transplantation

Medical imaging is the method and procedure of making visual representations of the inside of a body for clinical examination and therapeutic intercession, and additionally visual representation of the capacity of a few organs or tissues. Therapeutic imaging tries to uncover interior structures covered up by the skin and bones, and additionally to analyse and treat malady. Medicinal imaging likewise builds up a database of ordinary life structures and physiology to make it conceivable to distinguish variations from the norm. In spite of the fact that imaging of expelled organs and tissues can be performed for medicinal reasons, such methodology is typically considered a portion of pathology rather than restorative imaging.

  • Track 14-1Radiography
  • Track 14-2Functional near-infrared spectroscopy
  • Track 14-3Magnetic Resonance Imaging (MRI)
  • Track 14-4Nuclear medicine
  • Track 14-5Ultrasound
  • Track 14-6Elastography
  • Track 14-7Tactile imaging
  • Track 14-8Photoacoustic imaging
  • Track 14-9Thermography
  • Track 14-10Tomography
  • Track 14-11Echocardiography
  • Track 14-12Modern Radiotherapy and Quality assurance 

A biomarker, or biological marker, generally refers to a measurable indicator of some biological state or condition. The term is also occasionally used to refer to a substance the presence of which indicates the existence of a living organism. Further, life forms are known to shed unique chemicals, including DNA, into the environment as evidence of their presence in a particular location. Biomarker is a characteristic diagnostic tool that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes or pharmacological responses to a therapeutic intervention. Biomarkers can be molecules, or genes, gene products, enzymes, or hormones referred as protein biomarkers, analytical biomarkers, blood biomarkers, fluorescent biomarkers, circulating biomarkers and molecular biomarkers to quantify the degree of disease condition.Role of biomarkers in cancer research and medicine.

  • Track 15-1Protein biomarkers
  • Track 15-2Fluorescent biomarkers
  • Track 15-3Blood biomarkers: Serum and blood cells
  • Track 15-4Analytical biomarkers
  • Track 15-5Genetic Biomarkers
  • Track 15-6Molecular Biomarkers

Malignancy has a differentiated nature in connection to the organ specificity. The essential center is on heterogeneity, starting point, metastasis, angiogenesis and organ indicated systems in disease cells. There are diverse sorts of diseases taking into account area of tumor in the body organ. Organ-particular metastasis includes disease cell collaborations with the host microenvironment, including actuation of paracrine cytokine circles, change of the host cell sythesis, and modification of extracellular framework structures. Resistant cell avoidance, relationship with a strong specialty, and the capacity to open up survival pathways, frequently accomplished through association with the stroma, are vital for fruitful metastatic colonization.

  • Track 16-1Multistage Carcinogenesis
  • Track 16-2Urology Oncology
  • Track 16-3Otolaryngology cancers
  • Track 16-4Oral cancer
  • Track 16-5Thyroid Cancer
  • Track 16-6Gastrointestinal Cancer
  • Track 16-7Lung cancer
  • Track 16-8Renal cancer
  • Track 16-9Oncology : Psychological & Social Aspects
  • Track 16-10Blood cancer
  • Track 16-11Neuro-Oncology
  • Track 16-12Pediatric cancer
  • Track 16-13Heart cancer
  • Track 16-14Gynaecological Cancer
  • Track 16-15Endometrial cancer
  • Track 16-16Hemato-Oncology
  • Track 16-17Neuroblastoma
  • Track 16-18Oncology Cachexia
  • Track 16-19Ocular Melanoma
  • Track 16-20Osteosarcoma
  • Track 16-21Skin Cancer
  • Track 16-22Rectal Cancer

Oncogenomics is a relatively new sub-field of genomics that applies high throughput technologies to characterize genes associated with cancer. The study involves the research in to the Bioinformatics and functional analysis of oncogenes, which refers to the gene that has the potential to cause cancer. In tumor cells, they are often mutated or expressed at high levels. Cancer genome sequencing requires the development of new techniques utilizing Genomics and bioinformatics tools for target assessment, including both experimental protocols and data analysis algorithms, to enable a deeper understanding of complex biological systems.

Metabolomics is a newborn cousin to genomics and proteomics. Specifically, metabolomics involves the rapid, high throughput characterization of the small molecule metabolites found in an organism. The metabolome is closely tied to the genotype of an organism, its physiology and its environment (what the organism eats or breathes), metabolomics offers a unique opportunity to look at genotype-phenotype as well as.

  • Track 17-1Pharmacology
  • Track 17-2Pre-Clinical Drug Trials
  • Track 17-3Toxicology
  • Track 17-4Transplant Monitoring
  • Track 17-5Newborn Screening
  • Track 17-6Clinical Chemistry
  • Track 17-7Cancer Genome Sequencing
  • Track 17-8Cancer Transcriptomes
  • Track 17-9Bioinformatics And Functional Analysis Of Oncogenes
  • Track 17-10Comparative Oncogenomics
  • Track 17-11Databases For Cancer Research
  • Track 17-12Advances From Oncogenomics
  • Track 17-13Mutations In Mitochondrial DNA And Cancer
  • Track 17-14Potential Diagnostic Applications
  • Track 17-15Cancer Biomarkers

Carcinoma is a sort of cancer that develops from epithelial cells. In particular, a carcinoma is a malignancy that starts in a tissue that lines the internal or external surfaces of the body, and that generally arises from cells developing in the endodermal or ectodermal germ layer during embryogenesis. Carcinomas occur when the DNA of a cell is damaged or changed and the cell starts to develop wildly and get to be distinctly threatening. There are large numbers of rare sub types of anaplastic, undifferentiated carcinoma. Some of the more well-known cancers includes the lesions containing pseudo-sarcomatous segments: spindle cell carcinoma (containing prolonged cells resembling connective tissue malignancies), giant cell carcinoma (containing gigantic, peculiar, multinucleated cells), and sarcomatoid carcinoma (blends of shaft and monster cell carcinoma).

  • Track 18-1Invasive ductal carcinoma
  • Track 18-2Ductal carcinoma in situ
  • Track 18-3Renal cell carcinoma
  • Track 18-4Basal cell carcinoma
  • Track 18-5Carcinoma treatment and therapy option

Oncology is a standout amongst the most Focused zone in Cancer Treatments.For an Oncologist or Oncology Nurse, to locate an appropriate words to cheer a man who enduring with sickness. The specific medical caretaker is an enrolled nurture whose essential concentration in tumor mind.The advanced Oncology Nurse is master’s prepared nurse with learning and capacity in a range of malignancy nursing. All medical caretakers move along a way from learners to master. It is perceived that, paying little respect to regardless of the possibility that a generalist, specific oncology or propelled Oncology Nurse, every individual medical attendant will encounter this way from amateurs to master.

  • Track 19-1Clinical implications
  • Track 19-2Oncology Nursing Practice
  • Track 19-3Patient Care Measures
  • Track 19-4Primary Care and Oncology Nursing
  • Track 19-5Oncology Nursing and Cancer care
  • Track 19-6Psychological and psychosocial aspects and Cancer care
  • Track 19-7Effects of Cancer in chemotherapy and Oncology Nursing
  • Track 19-8Oncology Nursing in USA

As the researchers learn more about cancer, they’re developing new therapies that target particular types of tumor cells and restrict their growth. Blood carcinoma  is one of the major cancer that affect mainly blood, bone marrow, lymph and lymphatic system for treating this recent techniques have been discovered  by the researchers through targeting the tumor and restrict their growth. On their own or in combination with other alternative treatments, these therapies can decrease the size of tumors and symptoms. Some innovative therapies give hope for people with cancers that have been resistant to more treatments.

There are different stages of the cancer like Stage 1, Stage 2, Stage 3 and Stage 4. The Oncology Conference delivers practical ideas, solutions, and strategies to implement in cancer program today. This advance also speaks to the importance of value in cancer care. Value is a major focus for ASCO, because clinical benefit, toxicity, and cost must all be factored into shared decision making to determine the best treatment options for patients. ASCO is working to develop a physician-guided tool that will help patients evaluate new treatment options such as those highlighted in this report.

  • Track 20-1Cancer and lifestyle connection
  • Track 20-2Health education on Cancer prevention
  • Track 20-3Global Cancer Epidemiology
  • Track 20-4Cancer Nanotechnology

Medicinal chemistry and pharmaceutical chemistry are disciplines at the intersection of chemistry, especially synthetic organic chemistry, and pharmacology and various other biological specialties, where they are involved with design, chemical synthesis and development for market of pharmaceutical agents, or bio-active molecules (drugs).

Compounds used as medicines are most often organic compounds, which are often divided into the broad classes of small organic molecules (e.g., atorvastatin, fluticasone,clopidogrel) and "biologics" (infliximab, erythropoietin, insulin glargine), the latter of which are most often medicinal preparations of proteins (natural and recombinant antibodies, hormones, etc.). Inorganic and organometallic compounds are also useful as drugs (e.g., lithium and platinum-based agents such as lithium carbonate and cis-platin as well asgallium).

  • Track 21-1Medicinal Chemical Research
  • Track 21-2Medicinal Organic Chemistry
  • Track 21-3Synthetic Medicinal Chemistry’
  • Track 21-4Applied Medicinal Chemistry
  • Track 21-5Anticancer Agents in Medicinal Chemistry
  • Track 21-6Medicinal Biochemistry
  • Track 21-7Medicinal Companies and Market Analysis
  • Track 21-8Bioorganic Medicinal Chemistry
  • Track 21-9Chemical Pharmacology
  • Track 21-10Chemical Biology of Molecules
  • Track 21-11Anti-Allergic
  • Track 21-12Anti-Infective Agents in Medicinal Chemistry

Medical physics (also called biomedical physics, medical biophysics or applied physics in medicine) is, generally speaking, the application of physics concepts, theories and methods to medicine or healthcare. Medical physics departments may be found in hospitals or universities.

In the case of hospital work, the term 'Medical Physicist' is the title of a specific healthcare profession with a specific mission statement. Such Medical Physicists are often found in the following healthcare specialties: 

  • Track 22-1Intervention Radiology
  • Track 22-2Clinical Physiology
  • Track 22-3Radiation Protection
  • Track 22-4Medical imaging physics
  • Track 22-5Radiation therapeutic physics
  • Track 22-6Nuclear medicine physics
  • Track 22-7Health physics
  • Track 22-8Clinical audiology physics
  • Track 22-9Laser medicine
  • Track 22-10Medical optics
  • Track 22-11Neurophysics
  • Track 22-12Cardiophysics
  • Track 22-13Physiological measurement techniques
  • Track 22-14Physics of the human and animal bodies
  • Track 22-15Healthcare informatics and computational physics
  • Track 22-16Areas of research and academic development
Radiofrequency ablation (RFA) is a medical procedure in which part of the electrical conduction system of the heart, tumor or other dysfunctional tissue is ablated using the heat generated from medium frequency alternating current (in the range of 350–500 kHz). RFA is generally conducted in the outpatient setting, using either local anesthetics or conscious sedation anesthesia. When it is delivered via catheter, it is called radiofrequency catheter ablation.
 Two important advantages of radio frequency current (over previously used low frequency AC or pulses of DC) are that it does not directly stimulate nerves or heart muscle and therefore can often be used without the need for general anesthetic, and that it is very specific for treating the desired tissue without significant collateral damage
  • Track 23-1Tumors
  • Track 23-2Cardiology
  • Track 23-3Aesthetics Dermatology
  • Track 23-4Obstructive sleep apnea
  • Track 23-5Pain Management

Nano-oncology, the application of Nanomedicine to cancer diagnosis and treatment, has the potential to transform clinical oncology by enhancing the efficacy of cancer chemotherapy for a wide spectrum of invasive cancers. It achieves this by enabling novel drug delivery systems which target the tumour site with several functional molecules, including tumour-specific ligands, antibodies, cytotoxic agents, and imaging probes simultaneously thereby improving tumour response rates in addition to significant reduction of the systemic toxicity associated with current chemotherapy regimens. For this reason, nano-oncology is attracting considerable scientific interest and a growing investment by the global pharmaceutical industry. Several therapeutic nano-carriers have been approved for clinical use and others are undergoing phase II and III clinical trials. This paper describes the current approved formulations, such as liposomes and polymeric nanoparticles, and discusses the overall present status of nano-oncology as an emerging branch of nanomedicine and its future perspectives in cancer and therapy.

  • Track 24-1Clinical Application for Cancer Therapy and Future Perspectives
  • Track 24-2Use of Nanoparticles
  • Track 24-3Quantum Dots
  • Track 24-4Nanoparticles As Anticancer Agents
  • Track 24-5Nanobiotechnology in Cancer